Tourette syndrome is a neurological condition that has no cure but can be managed with various strategies—some of which are ...

Relmada Therapeutics has acquired complete worldwide ownership rights to Sepranolone from Sweden-based Asarina Pharma.

Relmada, which has turned to strategic options after scrapping two phase 3 trials in major depressive disorder (MDD), is ...

In PEOPLE's exclusive sneak peek at an upcoming episode of TLC's 'Baylen Out Loud', Baylen decides to try Botox for the first ...

Tourette syndrome is currently diagnosed about three times more frequently in males than in females. A new study finds that female individuals are less likely to be diagnosed with the syndrome, take ...

Larry Biederman, a high school science teacher, talks to us about how he handles being a teacher with Tourette's syndrome.

TLC seems particularly busy lately, announcing some new shows that take the channel in familiar directions and at least one ...

Relmada purchases Sepranolone, a Phase 2b ready asset, for the treatment of Tourette syndrome (TS) and other compulsion-related conditions from ...

Relmada Therapeutics (RLMD) announced the acquisition of Sepranolone, a Phase 2b ready neurosteroid, from Asarina Pharma AB, being developed ...

Jake Duraski, a LaGrange resident, was recently featured on an episode of the show, Baylen Out Loud. The series follows ...

Low-quality information on social media may be contributing to a rise in teen mental illness. A new construct may help ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...